These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 630293)

  • 1. MVPP chemotherapy regimen for advanced Hodgkin's disease.
    Sutcliffe SB; Wrigley PF; Peto J; Lister TA; Stansfeld AG; Whitehouse JM; Crowther D; Malpas JS
    Br Med J; 1978 Mar; 1(6114):679-83. PubMed ID: 630293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
    Oza AM; Ganesan TS; Dorreen M; Johnson PW; Waxman J; Gregory W; Lim J; Wright J; Dadiotis L; Barbounis V
    Br J Cancer; 1992 Mar; 65(3):429-37. PubMed ID: 1558800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's disease.
    Barnett MJ; Man AM; Richards MA; Waxman JH; Wrigley PF; Lister TA
    Hematol Oncol; 1987; 5(2):79-82. PubMed ID: 3596472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
    Dady PJ; McElwain TJ; Austin DE; Barrett A; Peckham MJ
    Br J Cancer; 1982 Jun; 45(6):851-9. PubMed ID: 7093120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of Hodgkin's disease in children.
    Kolygin BA
    Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
    Armata J; Borkowski W; Depowska T
    Am J Pediatr Hematol Oncol; 1984; 6(4):462-5. PubMed ID: 6549497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
    Armata J; Stopyrowa J; Depowski M; Strzeszynski J; Borkowski W; Kaczor Z; Depowska T
    Acta Paediatr Scand; 1978 May; 67(3):269-73. PubMed ID: 350007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
    Harding MJ; McNulty LJ; Paul J; Lee F; Brown A; Soukop M
    Eur J Cancer; 1991; 27(8):1002-6. PubMed ID: 1832882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
    Anderson H; Crowther D; Deakin DP; Ryder WD; Radford JA
    Ann Oncol; 1991 Feb; 2 Suppl 2():49-54. PubMed ID: 2049321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of stage IIIA Hodgkin's disease.
    Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
    J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPP.
    Wagstaff J; Steward W; Jones M; Deakin D; Todd I; Wilkinson P; Scarffe JH; Harris M; Crowther D
    Hematol Oncol; 1986; 4(2):135-47. PubMed ID: 2427429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
    Radford JA; Crowther D; Rohatiner AZ; Ryder WD; Gupta RK; Oza A; Deakin DP; Arnott S; Wilkinson PM; James RD
    J Clin Oncol; 1995 Sep; 13(9):2379-85. PubMed ID: 7666097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment failures and severe complications in children with Hodgkin's disease.
    Armata J; Borkowski W; Kaczor Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):406-11. PubMed ID: 6169602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of malignant lymphoma.
    Ong YW; Goh CN
    Ann Acad Med Singap; 1981 Jul; 10(3):281-7. PubMed ID: 7332296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
    McElwain TJ; Toy J; Smith E; Peckham MJ; Austin DE
    Br J Cancer; 1977 Aug; 36(2):276-80. PubMed ID: 911666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
    Smith PG; Wald N
    Br Med J; 1979 Apr; 1(6171):1105-8. PubMed ID: 444954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years.
    Dorreen MS; Wrigley PF; Laidlow JM; Plowman PN; Neudachin L; Tucker AK; Malpas JS; Stansfeld AG; Faux MM; Jones AE
    Cancer; 1984 Dec; 54(12):2882-8. PubMed ID: 6548658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
    J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.